statine: amine component of pepstatin; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 123915 |
| SCHEMBL ID | 8594 |
| MeSH ID | M0060721 |
| Synonym |
|---|
| heptanoic acid, 4-amino-3-hydroxy-6-methyl-, (3s,4s)- |
| inchi=1/c8h17no3/c1-5(2)3-6(9)7(10)4-8(11)12/h5-7,10h,3-4,9h2,1-2h3,(h,11,12)/t6-,7-/m0/s |
| (3s,4s)-4-amino-3-hydroxy-6-methylheptanoic acid |
| statine |
| 49642-07-1 |
| unii-ytc77xr1ek |
| ytc77xr1ek , |
| DFVFTMTWCUHJBL-BQBZGAKWSA-N |
| SCHEMBL8594 |
| (3s,4s)-statine |
| statine [mi] |
| statine, (-)- |
| HY-101877 |
| CS-7998 |
| (3s,4s)-(-)-statine |
| AKOS028114708 |
| mfcd00037277 |
| (3s,4s)-4-amino-3-hydroxy-6-methylheptanoic acid hydrochloride |
| Q7604197 |
| DTXSID00964315 |
| (3s,4s)-4-amino-3-hydroxy-6-methyl-heptanoic acid |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 27 (22.50) | 18.7374 |
| 1990's | 24 (20.00) | 18.2507 |
| 2000's | 27 (22.50) | 29.6817 |
| 2010's | 41 (34.17) | 24.3611 |
| 2020's | 1 (0.83) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 6 (4.69%) | 5.53% |
| Reviews | 8 (6.25%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 114 (89.06%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Article | Year |
|---|---|
| Effects of statin therapy on coronary artery plaque volume and high-risk plaque morphology in HIV-infected patients with subclinical atherosclerosis: a randomised, double-blind, placebo-controlled trial. The lancet. HIV, Volume: 2, Issue: 2 | 2015 |
| [information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | |
| Article | Year |
|---|---|
| Modified-policosanol does not reduce plasma lipoproteins in hyperlipidemic patients when used alone or in combination with statin therapy. Lipids, Volume: 46, Issue: 10 | 2011 |
| HIV proteinase inhibitors containing 2-aminobenzylstatine as a novel scissile bond replacement: biochemical and pharmacological characterization. Antiviral research, Volume: 25, Issue: 3-4 | 1994 |
| Why renin inhibitors? Journal of hypertension. Supplement : official journal of the International Society of Hypertension, Volume: 7, Issue: 2 | 1989 |
| [information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | |
| Article | Year |
|---|---|
| Modified-policosanol does not reduce plasma lipoproteins in hyperlipidemic patients when used alone or in combination with statin therapy. Lipids, Volume: 46, Issue: 10 | 2011 |
| [information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | |